In January, the cannabis sector experienced a significant gain. In our opinion, the gain wasn’t completely unexpected. If you look at December, the overall market was selling off. As a result, the valuations reached the oversold territory.

Do Cannabis Stocks Look Expensive?

YTD performance

In the above chart, you can see that cannabis stocks are off to a great start in 2019. Cronos Group (CRON) has risen nearly 89% YTD (year-to-date). Canopy Growth (WEED) (CGC) has risen nearly 62.3%, while Aphria (APHA) has risen nearly 55% during the same period. Aurora Cannabis (ACB) has risen nearly 45%. The Horizons Marijuana Life Sciences ETF (HMMJ) rose ~37.9% during the same period.

Now that cannabis stocks have risen, will the stocks become expensive due to the recent run-up?

Series overview

In this series, we’ll discuss the valuation multiples for the cannabis sector peers as a whole. We’ll also discuss the individual stocks that make up the peer group. We’ll discuss nine cannabis stocks. The valuation multiples that we’ll cover include the EV-to-sales and the EV-to-EBITDA multiples.

Latest articles

The future of the T-Mobile and Sprint merger remains unclear. Several state attorneys and Democratic senators have come together to oppose it.

According to President Trump, the US economy is “poised for big growth after trade deals are completed.” Markets are volatile amid the trade war.

Canopy Growth didn't impress investors with its earnings for the first quarter of 2020. The stock has fallen 12.4% since the company's earnings.

President Trump finally seems to acknowledge how the US-China trade war could impact tech giant Apple. Trump met with Apple CEO Tim Cook at a dinner.

As of August 13, HEXO (HEXO) was trading at 6.51 Canadian dollars—a fall of 30.9% since its third-quarter earnings on June 12.

On August 15, in an interview with CNBC, Mark Zandi said that the trade war hurts the US economy. The trade war has a negative impact on certain sectors.